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Abstract
Multimorbidity, the co-occurrence of two or more chronic diseases such as
diabetes, obesity or cardiovascular diseases in one patient, is a frequent phe-
nomenon. To make care more efficient, it is of relevance to understand how
different diseases condition each other over the life time of a patient. However,
most of our current knowledge on such patient careers is either confined to
narrow time spans or specific (sets of) diseases. Here, we present a population-
wide analysis of long-term patient trajectories by clustering them according
to their disease history observed over 17 years. When patients acquire new
diseases, their cluster assignment might change. A health trajectory can then
be described by a temporal sequence of disease clusters. From the transitions
between clusters we construct an age-dependent multilayer network of disease
clusters. Random walks on this multilayer network provide a more precise
model for the time evolution of multimorbid health states when compared to
models that cluster patients based on single diseases. Our results can be used to
identify decisive events that potentially determine the future disease trajectory
of a patient. We find that for elderly patients the cluster network consists of
regions of low, medium and high in-hospital mortality. Diagnoses of diabetes
and hypertension are found to strongly increase the likelihood for patients to
subsequently move into the high-mortality region later in life.
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Noncommunicable (or chronic) diseases (NCDs) such as dorsalgia, hypertension,
respiratory diseases or diabetes affect a large fraction of the world’s population and
decrease the quality of life of people burdened by them [1]. For example, in 2004,
almost 50% of the population of the United States was suffering from at least one
chronic condition [2] and in 2014, approximately 25% of the adults had been di-
agnosed with more than one NCD [3], with both numbers strongly increasing with
age. Besides having a negative impact on people’s wellbeing, NCDs also pose a
substantial burden on the healthcare systems of countries [4, 5]. Apart from com-
batting common risk factors such as unhealthy lifestyle and diet, which many NCDs
are attributed to [6], early detection and management play a key role in decreasing
the burden of chronic diseases [7]. Personalized (or stratified) medicine promises
to make care more efficient by tayloring treatments individually to patients while
taking their individual risk profile for potential future diseases into account [8]. A
necessary precondition to enter this new era of medicine is a deepened understanding
of how the long-term developments of multiple diseases condition each other.
The field of network medicine holds as central tenet that diseases cannot be
studied independently from each other but arise from complex interactions between
molecular units in the human body in terms of discretized structures such as protein–
protein, metabolic, regulatory and RNA networks [9]. For example, the fact that
many diseases tend to be comorbid, i.e. that they tend to co-occur in patients, can
be understood based on disease-causing genes or pathways shared by the comorbid
diseases [10, 11, 12]. However, not all diseases linked by shared genes exhibit sig-
nificant comorbidities, as different mutations of the same gene can have different
consequences. Conversely, not all comorbidities can be explained from molecular
data. One reason is that comorbidities can also be the result of the exposure to the
same environmental risk factors, for example, due to a particular lifestyle [13]. In
addition, present data on molecular interactions is far from being complete [14].
To obtain a more empirically-based understanding of disease comorbidity, obser-
vational healthcare data regarding hospital admissions, pharmaceutical prescriptions
and doctor visits has been leveraged for the purpose of disease prediction and to re-
veal previously unknown molecular connections between diseases [15, 16]. Using
so-called phenotypic comorbidity networks [17, 18, 19, 20]—networks where nodes
represent diseases and two nodes are linked if the two corresponding diseases are
comorbid— it was shown that diseases which are comorbid to many other diseases
have a higher mortality and that patients tend to develop diseases in close network
proximity to the ones they already have. The latter fact opens up the possibility
to predict future diseases of patients based on their medical history. This has been
accomplished with approaches that include collaborative filtering [21, 22], frequent
itemsets [23, 24], learning of transition probabilities between states represented by
binary vectors [25, 26], deep learning [27, 28] and point processes [29].
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Next to predicting future disease, longitudinal data on hospital admissions allows
the identification of previously unknown patterns in the temporal sequence of dis-
eases (health trajectories) patients are diagnosed with. By analyzing the temporal
order of diagnosis pairs co-occuring in a significant number of patients with a partic-
ular directionality in time, it was possible to identify such trajectories with a length
of up to four diseases [30]. Alternative methodological approaches to identify typical
health trajectories include dynamic time warping [31], a method originally developed
for speech recognition, or the detection of putative causal relations between pairs of
diseases using information-theoretic approaches [32]. The major challenge all these
works are confronted with is the high number of different diagnosis codes, leading
to a combinatorial explosion of the number of possible disease combinations, many
of which occur only in a single patient.
Here we present an alternative approach to characterize the population of an
entire country in terms of its long-term health trajectories. An illustration of our
work flow is shown in Fig. 1. First, Fig. 1A, we represent the health state of a patient
at a given point in time by a binary vector encoding the set of diseases he or she has
been diagnosed with so far. Based on a longitudinal data set covering all intramural
stays in Austria from 1997 until 2014, see Methods, we consider the yearly disease
vectors of all patients without any hospital admission between 1997 and 2002. The
set of all health states (disease vectors) is then partitioned using a divisive clustering
algorithm called DIVCLUS-T [33], Fig. 1B. Each cluster is defined by a set of diseases
which each patient in that cluster has been diagnosed with (inclusion criteria) and
a set of diseases each patient in that cluster has not been diagnosed with (exclusion
criteria). As time proceeds, patients acquire new diseases and consequently can
change the cluster they belong to, see Fig. 1B. The sequence of clusters a patient
belongs to throughout the observation period describes his or her health trajectory.
We construct a multiplex network where nodes represent clusters, layers correspond
to different patient sex and age groups. Directed links in the multiplex layers are
weighted according to the rate at which patients of the corresponding sex and age
group change between the two clusters corresponding to the nodes, see Fig. 1C.
Our approach therefore provides a statistical description of the disease progression
of patients which takes into account their sex, age and entire observed history of
hospital diagnoses.
1 Results
Our study cohort consists of the M = 5, 112, 811 patients who did not receive a
diagnosis with ICD-10 code from A00 to N99 in 1997–2002 and received at least one
diagnosis with ICD-10 code from A00 to Z99 in 2003–2014. Figure S2 in the Sup-
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Figure 1: Illustration of the workflow from the input data to a multiplex network model of disease
progression. (A) From the input data, we extract the observed health states of patients in the cohort
at the end of each year of the observation period, represented by binary vectors. (B) All sampled
health states are assigned to clusters using the DIVCLUS-T algorithm. For each patient we thereby
obtain a sequence of clusters he or she is assigned to over the years (the health trajectory). (C)
From the health trajectories of patients, we construct a multiplex network, where nodes represent
clusters, layers represent age and sex groups and directed links between the nodes are weighted
according to the rates at which patients change between the corresponding clusters.
plementary Information (SI) shows the distribution of the dates of birth of patients
of this cohort; 53% of them are female.
1.1 Disease clusters
For each patient we observe thirteen disease vectors (from the end of each year in
the observation period 2002–2014) which are grouped into 132 disease clusters by
DIVCLUS-T, see Methods. Tables detailing the inclusion and exclusion criteria of
all clusters can be found in SI, section 8. There and in the main text, the symbols
7 and 3 next to a diagnosis block indicate that this block is an exclusion, respectively
an inclusion criterion for that cluster. Since all patients are free from any (known)
prior diagnoses, all patient trajectories start in cluster 0 (the “healthy cluster”),
where all diagnoses are exclusion criteria.
In Fig. 2a we show the sizes, meaning the total number of observations, assigned
to each cluster. Note that the cluster IDs are given by their rank after being sorted
by size. Color in Fig. 2a shows the sex distribution within the clusters. There are
several clusters only containing patients of one sex; this is explained by sex specific
inclusion criteria such as ‘Diseases of male genital organs’ (N40–N51). There are,
however, also clusters with a high sex imbalance that is less easily explained. For
example, 82% of the patients in cluster 83 are male. For this cluster, the inclusion
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criteria are ‘Mental and behavioral disorders due to psychoactive substance use’
(F10–F19) and ‘Diseases of liver’ (K70–K77).
A two-dimensional histogram of the age distributions in the different clusters
is shown in Fig. 2b. Clusters differ strongly in their age composition, with a high
number of clusters where the distribution is centered around ages 60–80. In Fig. 2c
we compare the mean age of patients in a cluster with the probability that a patient
who enters this cluster stays there and dies in-hospital within the observation period
(hospital release type death). We refer to this probability as the cluster mortality.
Mortality tends to increase with the mean age of patients in a cluster, however,
for a given mean age, the spread of the cluster mortality can extend over more
than one order of magnitude. The maximum mortality value of 38% is measured
for cluster 68, which has no exclusion criteria and includes hypertensive diseases
(I10–I15), other forms of heart disease (I30–I52), diseases of arteries, arterioles and
capillaries (I70-I79) and a diagnosis of renal failure (N17–N19). Moreover, 67% of
the health states assigned to that cluster include metabolic disorders (E70-E90) and
49% include diabetes mellitus (E10-E14).
1.2 Health trajectories
As patients acquire new diseases from one year to the next, they can transition
between clusters, see Methods. The time sequence of clusters that a patient has
visited defines his or her trajectory. We also define the reduced health trajectory of a
patient as the health trajectory with all repetitions removed. For example, if patient
i has the health trajectory (1, 1, 5, 5, 5, 3), then his or her reduced health trajectory
is (1, 5, 3). The blue bars in Fig. 2d show the distribution of the mean length of the
reduced health trajectory of patients during the observation period. Almost 25%
of the patients stay in cluster 0 during the entire time span (only received codes
from the ICD chapter O–Z); 2% visit four or more clusters. Fig. 2e shows how
the length of the reduced health trajectory of patients varies with age. Adolescent
patients visit the least number of clusters, and patients around the age of 70 visit
the highest number of clusters. The most frequent reduced trajectory of length 3
is (0,2,31), and is followed by 5,983 individuals; Fig. 2f. Patients with this reduced
trajectory first acquire a diagnosis from the block ‘Arthropathies’ (M00–M25) and
subsequently one from the block ‘Soft tissue disorders’ (M60–M79).
We now describe results for typical health trajectories involving the diagnosis
blocks of ‘Cerebrovascular diseases’, ‘Malignant neoplasms’ and ‘Mood [affective]
disorders’.
Cerebrovascular diseases (I60–I69). A total of 199,681 patients (3.9%) were
diagnosed with cerebrovascular diseases. The distribution of the length of their
reduced trajectories is clearly shifted towards higher values compared to the total
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Figure 2: (A) Number of observations assigned to the different clusters, color coded by the ratio
of females in the cluster. (B) Two-dimensional histogram of the age distribution in the different
clusters. (C) Scatter plot of mortality versus mean age in the different clusters with color indicating
their sex ratios. (D) Relative distribution of the number of clusters visited during the observation
period for all people in the cohort (blue), patients diagnosed with cerebrovascular diseases (red,
I60–I69), malignant neoplasms (green, C00–C97) and mood [affective] disorders (magenta, F30–
F39) during the observation period. (E) Mean number of clusters visited by patients during the
observation period depending on their age at the beginning of the observation period. (F) Illustra-
tion of the reduced trajectory (0,2,31), which is the most frequent reduced trajectory of length 3
and followed by 5,983 patients of the cohort. The numbers underneath the arrows give the total
number of patients who step from cluster 0 to cluster 2 and from cluster 0 to cluster 2 to cluster
31, respectively.
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cohort; see Fig. 2d. The most frequent reduced trajectory of length three, followed
by 1,447 patients, is (0,32,48), meaning that patients from the “healthy cluster” 0
(all diseases are exclusion criteria) move to cluster 32 with hypertensive diseases
(I10–I15) and heart diseases (I30–I52) to cluster 48 where cerebrovascular diseases
(I60–I69) changed from an exclusion (cluster 32) to an inclusion criterion (cluster
48).
Malignant neoplasms (C00–C97). A total of 312,787 patients (6.1%) re-
ceived a diagnosis from the block ‘Malignant neoplasms’. The distribution of the
number of visited clusters visited by these patients is shown in Fig. 2d and shifted
toward higher values with respect to all other patients. More than 50% of them only
visit two different clusters, and 44% (69,552) of those patients have the reduced tra-
jectory (0,12), i.e., from the healthy cluster to a cluster where cancer (C00–C97)
is the only inclusion criterion. The most frequent reduced trajectory of length 3,
followed by 3,093 cancer patients, is (0,12,38) where patients acquire hypertensive
diseases (I10–I15) after cancer.
Mood [affective] disorders (F30–F39). A total of 210,589 patients (4.1%)
of the study cohort are diagnosed with mood or affective disorders during the ob-
servation period. The distribution of their reduced trajectory lengths is shown in
Fig. 2d and again shifted toward higher lengths compared to all patients. Among
these patients, 9.5% end their trajectory in cluster 55, where additional to ‘Mood
[affective] disorders’, patients are diagnosed with a diagnosis from the block ‘Mental
and behavioral disorders due to psychoactive substance use’ (F10–F19). The most
common reduced trajectory of length 3 in this subcohort, followed by 1,936 patients,
is (0,14,55). These patients first acquire a diagnosis from the block F10–F19, and
subsequently one from the block F30–F39.
1.3 Disease cluster multiplex network
Separately for males and females, we construct a directed multiplex dynamic net-
work,M, where nodes represent patient clusters and layers (time slices) correspond
to age and sex groups. A directed link from node i to node j within time slice a in
the network for patients of sex g has a weight proportional to the number of observed
transitions from cluster i to j of patients with corresponding age and sex. Fig. 3
shows a visualization of the dynamic network of clusters of patient health states,
filtered and collapsed into one layer. Nodes correspond to clusters and their size is
the number of observations in that cluster; node color corresponds to cluster mor-
tality on a scale from 0% (blue) to 38% (red). Links indicate a significant number
of transitions between two clusters of patients with an average age that is encoded
into the link color from 0y (light green) to 80y (black). The layout in Fig. 3 has
been generated in a force-directed way, after which the nodes were displaced from
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Figure 3: Plot of the collapsed dynamic network M, where nodes represent clusters and directed
edges between the nodes are weighted according to the transition probability between the two nodes.
The edges are colored depending on the mean age of the patients who make the corresponding step.
Light green edges indicate a low mean age and dark green edges indicate a high mean age of the
patients making the corresponding step. The size of the nodes is scaled according to the size of the
corresponding cluster and the node color indicates the cluster mortality, with blue indicating low
mortality and red indicating high mortality. The node representing cluster 0, which is connected
to all other nodes, has been removed in this visualization. The layout has been generated by a
force-directed algorithm after which nodes have been displaced from left to right by a distance
proportional to the average age associated with its links, i.e., patient age increases from left to
right. To increase the readability, we only display the 255 strongest links of the network. For
elderly patients we observe network regions of low, medium and high mortality. Clusters 24 and
34, which are identified as gatekeepers to the sink state, are marked with red circles; the sink state
cluster 68 is annotated.
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left to right by a distance proportional to the average age of patients in the cluster.
As patients age (move from left to right in the network), they either reach a region
of low or high mortality. The low mortality clusters for the elderly (clusters 25, 102,
105) are characterized by having various diseases of the eye as inclusion criteria and
most other diseases as exclusion criteria. Contrast this to the high mortality region
for the elderly that is often accessed via cluster 24 (including hypertensive, I10–I15,
and diabetes, E10-E14) or cluster 26 (with hypertensive diseases and metabolic dis-
orders, E70–E90). Cluster 68 is a sink state of our dynamic multiplex network, i.e.
has zero out-strength, and lies within the high-mortality region. Note that the fact
that there exists such a sink state is a consequence of our choice of clustering algo-
rithm. There are clusters for younger patients with links pointing toward the low
and high mortality regions, such as cluster 2 (including arthropathies, M00–M25) or
cluster 29 (diseases of the oesophagus, stomach, and duodenum, K20–K31). While
cluster 68 has a balanced sex ratio (49% females), many clusters with direct links
to 68 have an overrepresentation of females (65% in cluster 118, 52% in 58, 59%
in 48). Additionally, we find a region of medium mortality for the elderly made up
of clusters that include arthropathies and osteopathies (M80–M94), cluster 43, or
additionally soft tissue disorders (M60–M79), cluster 117.
1.4 Gatekeeper clusters
We identify “gatekeeper clusters” strongly increasing the risk of cardiovascular mor-
tality by using a stochastic model of disease progression. Precisely, we model health
trajectories as random walks on the disease cluster multiplex networkM, see Meth-
ods.
For a given cluster k, we term as gatekeepers to k those clusters which tend to
be visited by many patients early in their medical career and where patients visiting
that cluster have, according to our random walk model, an increased probability to
visit cluster k during their lifetime. For the high-mortality cluster 68 (the sink state),
we identify cluster 24 as a gatekeeper, highlighted red in Fig. 3; see SI for details.
Patients in that cluster necessarily have been diagnosed with diabetes mellitus (E10-
E14) and hypertensive diseases (I10-I15), but have not yet received diagnoses of
obesity and other hyperalimentation (E65-E68), metabolic disorders (E70-E90) and
other forms of heart disease (I30-I52). The probability that a patient of the cohort
who enters into cluster 24 will reach cluster 68 during his or her lifetime according to
our model is 0.23, and is hence increased by approx. 40% compared to the baseline
probability of 0.16 for all patients of the cohort. Another closely related gatekeepers
is clusters 34 (metabolic, hypertensive, and ischaemic heart diseases but no diabetes
and no other forms of heart diseases), for which the probability to reach cluster 68
increases by approx. 50–60%. Clusters 34 is also highlighted red in Fig. 3.
9
2 Discussion
We presented a novel method to describe patient trajectories as observed over 17y
from a population-wide data set on hospital diagnoses. The method is based on
partitioning observed medical histories of patients into a small number of clusters.
A statistical analysis of the transition rates between clusters enabled us to create a
model which can be used to simulate synthetic patient trajectories as random walks
on a multiplex network.
We show that elderly patients can be found in regions of low, medium and
high mortality. The high mortality region is characterized by the co-occurrence of
multiple chronic conditions ranging from diabetes, cardiovascular diseases, coronary
heart disease, to renal failure; most of these diseases are exclusion criteria in the low
mortality region for the elderly, where they only suffer from diseases such as senile
cataract. Although morbidity and mortality attributable to cardiovascular diseases
decreased in the last decade (with greater improvement in men), they remain the
predominant causes of mortality in both sexes. On the other hand NCDs like obesity,
metabolic disorders, diabetes and renal diseases increased in men and women, partly
due to population aging. The comorbid prevalence of diabetes and renal disease and
failure markedly increases cardiovascular morbidity and mortality. Patients with
renal diseases hardly achieve the targets for blood pressure and glycemic control.
However, the use of new classes of antidiabetic drugs may change the paradigm of
ineluctable cardiorenal risk in the future [34].
Some patients enter the region of high mortality and high disease burden at an
older age via the low mortality region in Fig. 3. For others, however, the course
toward high mortality is already set at much younger ages. For instance, cluster
46 consists of patients with an average age of 44y, metabolic disorders (E70–E90)
and about thirty other diagnosis blocks as exclusion criteria. From this cluster there
is a link to cluster 34 where patients additionally receive diagnoses of hypertensive
and ischaemic heart diseases, after which disease and mortality burden are bound to
increase further. This is in line with findings that patients with metabolic syndrome
have an almost threefold increased mortality because of cardiovascular or coronary
heart disease in an 11.4y follow up [35]. In this sense, patients with metabolic
disorders appear to be locked in on a path toward high mortality already at much
younger age (say, between 40y and 50y).
We identified several gatekeeper clusters that can be loosely seen as “points of
no return” toward the high mortality network region. By identifying how patients
transition into these gatekeeper clusters, we find that diabetes mellitus and hy-
pertension often stand at the beginning of the medical career of patients. These
diseases substantially increase their probability to subsequently move into the high-
mortality region of the cluster network. Diabetes and hypertension are the most
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prominent risk factors for development of both renal failure and cardiovascular dis-
ease. Unfortunately, they are often undetected and only diagnosed because of acute
complications caused by the underlying disorders. For example, in Denmark 35% of
the patients with newly diagnosed diabetes featured diabetic complications around
diagnosis [36]. As patients usually suffer from diabetes for many years before the
diagnosis, screening and prevention programmes are necessary at least for subjects
at high risk. It is highly recommended that patients with the clinical features hy-
pertension, vascular diseases, dyslipidemia, prediabetes or abdominal obesity, often
clustering as metabolic syndrome, should as early as possible and all (other) subjects
older than 45 years undergo diabetes screening at regular intervals [37]. Such proce-
dure could help to identify more patients at risk earlier and to implement secondary
prevention of long-term complications and assure guidelines-based therapy.
Females are overrepresented in several clusters with direct links to the high-
mortality cluster 68, which in itself has a balanced sex ratio. Both diabetes and
renal failure appear to attenuate the generally positive effect of female sex on life
expectancy: these disorders seem to increase risk in women to a greater extent,
thereby equalizing mortality risks [38, 39, 40]. This may be ascribed to sex-dimorphic
changes in risk factor burden and enviromental factors. Among patients with type
2 diabetes, which comprises more than 90% of all diabetes cases, women with type
2 diabetes were shown to be more likely obese, hypertensive and to have hyperc-
holesterolaemia but were less likely to be prescribed lipid-lowering medication and
antihypertensive drugs, especially if they had cardiovascular disease in comparison
to men [41]. Moreover it was shown that admissions for acute myocardial infarc-
tions steadily increased in the last two decades especially in younger patients whose
history of diabetes and hypertension increased in parallel [42]. The proportion at-
tributable to younger women was particularly high who also had lower probability
of receiving guideline-directed therapy.
Limitations of this work include that we do not know the health history of pa-
tients prior to the observation period. Also, the data only contains health informa-
tion from hospital stays but not from outpatient contacts or doctor visits. Moreover,
the fact that the data was originally recorded for billing purposes means that diag-
noses which do not lead to financial reimbursement were often not reported. The
actual disease burden of patients might therefore be underrepresented in our data.
Simulated trajectories might occur that are logically not possible. The model might
produce a patient trajectory starting in cluster A, with disease d as an inclusion
criterion, stepping to cluster B, where d is neither an exclusion nor an inclusion cri-
terion, and from there to cluster C, where d is now an exclusion criterion. To assess
the quality of the trajectory model, we compared our results with different bench-
mark models that assign patients to clusters based on single diseases (either the most
recent or least frequent one) rather than using exclusion criteria. These benchmarks
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perform either comparable or only slightly worse than the DIVCLUS-T approach in
terms of cluster inertia. This can be understood from the fact that the benchmark
models nevertheless capture disease–disease correlations (note that for a given clus-
ter, the cluster-specific frequencies of other diseases are the marginal frequencies of
the diseases computed over all patients fulfilling the criteria for that cluster). How-
ever, if we take the longitudinal component of the data into account and compare
the statistics of simulated and real patient trajectories, we find that our approach
clearly outperforms the benchmark models. This confirms that the issue of logically
impossible trajectories does not substantially impact our results. In addition, these
results reveal that our multiplex network approach based on multimorbidity clus-
ters provides a more adequate framework to capture the path-dependent nature of
long-term health trajectories compared to the single-disease benchmark models. It
will be of interest to extend the current framework with additional clinical variables
or to focus on more specific subsets of patients for a more precise identification of
disease gatekeepers.
Data and Methods
A Data
We analyze a data set provided by the Austrian Federal Ministry for Health, covering all approx.
45M hospital stays of about 9M individuals in Austria during the 17 years from 1997 until 2014.
Here, the term hospital also includes facilities of long-term care such as rehabilitation centers or
psychiatric hospitals [43]. For each stay of a patient, the data includes sex, age group (5y interval),
admission and release date, release type (release, transfer, death), as well as in total about 120M
main or side diagnoses in the form of level-3 ICD-10 codes [44]. We restrict our analysis to 1,074
codes from A00 to N99, as the remaining codes relate to medical conditions that do not necessarily
reflect diseases. Due to the similarity of the conditions described by many codes, we group them
into 131 blocks as defined by the WHO. For example, the codes from E10 to E14 form the block
‘Diabetes Mellitus’. A list of all diagnosis blocks can be found in section 9 of the Supporting
Information (SI) to this article. To make sure that the patients are in a well defined health state
at the beginning of the observed time period, we restrict the analysis to all patients not assigned a
diagnosis from the range A00 to N99 during a hospital stay in Austria in the period from 1997 to
2002 inclusively.
B Clustering
The (observed) health state of a patient at a given point in time consists of all diseases he or she has
been diagnosed with until that point. We represent the health state of a patient i (1 ≤ i ≤ M) at
time t by a binary vector x(i)(t) = (x
(i)
1 (t), . . . , x
(i)
N (t)), where N denotes the total number of disease
codes, and x
(i)
j (t) is one if patient i has been diagnosed with disease j until time t and zero else.We
choose a set of equidistant time values T = {t0, . . . , tn}, where ti+1 − ti = ∆ (1 ≤ i < n), at which
we sample the health state of each patient. The parameter ∆ controls the temporal resolution of the
analysis. The values t0 and tn mark the start and end point of the observation period, respectively.
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We use a divisive clustering algorithm called DIVCLUS-T [33], to partition the set of observed
health states of patients with at least one diagnosis into K = 131 clusters; see SI, section 2. An
additional cluster contains all health states of patients who did not receive any diagnose yet. The
DIVCLUS-T algorithm aims to minimize the same objective function as the well-known Ward’s
method and the k-means algorithm, but produces results which are easier to interpret. More
precisely, each cluster is defined by a set of diseases which all patients in that cluster have been
diagnosed with and a set of diseases which all patients in that cluster have not been diagnosed with.
We refer to these sets as the inclusion, respectively the exclusion criteria for that cluster.
C Analysis of cluster transitions
Denote for t ∈ T by Ci(t) the cluster to which observation x(i)(t) is assigned. The sequence
Si = (Ci(t0), . . . , Ci(tn)) describes the health trajectory of patient i throughout the observation
period. We also define the reduced health trajectory of a patient as the health trajectory with all
repetitions removed. If for a given 1 ≤ i ≤ M and 1 ≤ s < n, Ci(ts) = k and Ci(ts+1) = j, then
we say that patient i steps from cluster k to cluster j. For each pair of clusters 1 ≤ k, j ≤ K,
there exists at least one disease which is an exclusion criterion in one and an inclusion criterion in
the other cluster. Since we represent patients by all diseases which they have been diagnosed with
so far, a patient cannot step from a cluster in which a certain disease is an inclusion criterion to
one where this disease is an exclusion criterion, and therefore, steps between two clusters are only
possible in one direction.
The cohort is stratified into groups according to sex and age. For a given sex g and age group
a, we define sg,a,k,j as the number of patients of sex g and age group g who step from cluster k to
cluster j; the value
qg,a,k,j =
sg,a,k,j∑K
j=1 sg,a,k,j
(1)
is the rate at which patients of this sex and age group make this step.
D Modeling health trajectories
To simulate the future trajectory of a patient, we first determine his or her starting position accord-
ing to age and history of medical diagnoses. Let at time t0 the patient be in cluster k on time slice a
of the network. Then we randomly choose the position of this patient at time t1 = t0+∆, such that
with probability qg,a′,k,j , his or her next position is in cluster j on time slice a
′; the time slice a′ is
determined from the age of the patient at time t1. To compare results of our method to simulate
random health trajectories with the health trajectories observed, we simulate as many synthetic
health trajectories as there are patients in our study cohort, with the same sex and age distribution
as our cohort. The initial condition of the model is taken from the data, i.e., all patients start their
trajectory in the “healthy” cluster where all diseases are exclusion criteria (cluster zero). To assess
the quality of the simulated health trajectories, we compute several metrics for comparing disease
frequencies according to the simulated trajectories with the data, and compare the performance of
our method in terms of these metrics with two benchmark models, see SI. Fig. S4 (b) in the SI
shows the forecasted distribution of patients of the study cohort over the different clusters at the
end of their lives.
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1 Data
Fig. 1 shows a two-dimensional histogram of the number of distinct diagnoses which patients in the study
cohort acquire during the observation period from 2003 to 2014, depending on their age. The number of
distinct diagnoses is larger for older people, indicating an increase in comorbidity with age.
The distribution of the dates of birth of patients in the study cohort is shown in Fig. 2.
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Figure 1: Two-dimensional histogram of the number of distinct diagnoses acquired by patients of the study cohort in the
observation period from 2003 to 2014, depending on the 5-year age group they belong to in 2014. The data is normalized such
that values sum to one separately for each age group.
2 Clustering algorithm
The divisive hierarchical clustering algorithm which we use in this work is called DIVCLUS-T, and was
presented in [1]. It is similar to the well established Ward’s minimum variance method [2] and the k-means
algorithm [3, chap. 20] in that it aims to optimize the same objective function as these two clustering
methods, but increases interpretability due to the fact that its results can be read like a decision tree.
The input data passed to the algorithm is in the form of a binary matrix X ∈ {0, 1}M×N , recording M
observations of N different features. The element of X which stands in the ith row and jth column is denoted
by Xi,j , where 1 ≤ i ≤ M and 1 ≤ j ≤ N . We also denote for 1 ≤ i ≤ M the binary vector representing
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Figure 2: Distribution of the dates of birth of patients in the study cohort. The data is normalized such that the bar heights
for males and females sum to one separately.
one particular observation by x(i) = (Xi,1, . . . , Xi,N ). In our application, one row of X corresponds to the
health state of one patient, observed at a certain time, and each column corresponds to a particular block of
diagnoses. For example, if column j represents the diagnosis block ‘Diabetes Mellitus’, then Xi,j = 1 if the
patient represented by row i has been diagnosed with diabetes until the point in time the observation was
made, and 0 otherwise. In our implementation of the algorithm, the user further specifies a binary vector
v ∈ {0, 1}N , a real, non-negative vector w ∈ [0,∞)N , as well as two positive integers θ and K.
Starting from the root node, the algorithm iteratively constructs a binary tree where each node k represents
one particular subset Sk of the total set of observations S0 = {1, . . . ,M}, and Sk ⊃ Sj if and only if node k
is an ancestor of node j; the set S0 is represented by the root node. To each node k is further associated a
vector p(k) = (p
(k)
1 , . . . , p
(k)
N ) ∈ [0, 1]N , defined as
p(k) =
1
|Sk|
∑
i∈Sk
x(i). (1)
Geometrically, p(k) is the centroid of the |Sk| binary vectors represented by node k, embedded into RN . For
1 ≤ j ≤ N , the value p(k)j is the probability that an observation, randomly selected from Sk, has feature j.
The inertia of a node k is defined as
Ik =
∑
i∈Sk
‖w ◦ (xi − p(k))‖22 = |Sk|w ·
(
p(k) ◦ (1− p(k))
)
, (2)
where ‘◦’ denotes the coefficientwise product, ‘·’ is the Euclidean scalar product, 1 = (1, . . . , 1) and ‖ · ‖2
denotes the Euclidean norm. For a given feature 1 ≤ j ≤ N , the value p(k)j (1 − p(k)j ) is the variance of the
set of points {xi | i ∈ Sk}, projected onto the jth axis. It can therefore be regarded as a measure for how
homogeneous the observations belonging to Sk are with respect to feature j. The inertia Ik quantifies the
overall inhomogeneity of the observations represented by note k, averaged over all the features, weighted
according to the entries of w. Note that our use of the letter w differs from [1], where weights were assigned
to observations.
Let after any number of iterations of the algorithm node k be a leaf node of the tree constructed thus far.
To simplify the notation, we drop the index k and let S be the set of observations represented by that node.
Define for a given feature 1 ≤ j ≤ N the subsets Sj0 = {i ∈ S | Xi,j = 0} and Sj1 = {i ∈ S | Xi,j = 1}. Hence,
the sets Sj1 and S
j
0 partition the set S into those observations which do or do not have feature j, respectively.
Among the features 1 ≤ j ≤ N for which vj = 1, the algorithm now selects the feature
j0 = argmin
j∈J
(
Ij0 + I
j
1
)
, (3)
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Figure 3: Discrepancy between synthetic and real trajectory counts in % of the real trajectory counts for all trajectories followed
by more than 1000 patients.
where Ij0 and I
j
1 are the inertias of S
j
1 and S
j
0, respectively, and
J =
{
1 ≤ j ≤ N ∣∣ vj = 1 ∧ min(|Sj0|, |Sj1|) > θ}. (4)
Node k now becomes the parent node of two newly created leaf nodes representing the subsets Sj00 and
Sj01 , respectively. The feature j0 is hence the feature used to split of node k; the vector v specifies which
features are allowed to be used to split up nodes.
After a certain number of iterations, the set J is empty for each leaf node, and the algorithm therefore
stops. Assume that the number of leaves of the generated tree is L and denote the sum of the inertias of all
leaves of this tree by F . By removing two leaves of the tree with common parent node, we obtain a pruned
tree of L− 1 leaves where the parent node is now a leaf. Denote the sum of the inertias of all leaves of this
new tree by F ′. We remove the pair of nodes with common parent node such that the difference F ′ − F is
minimal. By repeating this procedure L −K times, we arrive at a tree with K nodes. We denote the sets
represented by the leaves of this tree by C1, . . . , CK . They form a partition of the set S0 = {1, . . . ,M}, and
hence give a clustering of the observations contained in X into K disjoint subsets.
Suppose we are given a certain observation but do not know which cluster it belongs to. To determine the
cluster membership of that observation, we proceed as follows. Starting from the root node, we ask whether
the feature which was used to split up the root node is present in the observation or not, and, accordingly, we
move on to the child node of the root which has or does not have this feature, respectively, and so forth, until
we arrive at a leaf node (i.e., a cluster). The cluster membership of any observation can thus be determined
by a finite sequence of binary questions. It is this property which distinguishes it from Ward’s method and
the k-means algorithm, and which increases the interpretability of the results obtained. However, this comes
at the cost of restricting the set of possible cluster partitions, and therefore potentially less optimal solutions.
Specifically in this work, we set θ = 1000, v = (1, 1, . . . , 1), and the entries of the weight vector w =
(w1, . . . , wN ) are set as
wj = − ln(pj) for 1 ≤ j ≤ N, (5)
where pj =
1
M
∑M
i=1Xi,j is the probability that a randomly selected patient of the cohort, observed at a
uniformly selected time in T , has been diagnosed with disease j so far. The quantity on the right of Eq. (5)
is known as the inverse document frequency (idf), a commonly used measure in text analytics [4]. The
idea behind idf is that terms appearing less frequently in a corpus of documents are more distinctive to a
text which contains them. In our context, documents correspond to observations and words correspond to
individual diseases.
The objective function aimed to be minimized by DIVCLUS-T is
F =
K∑
k=1
Ik,
3
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Figure 4: Distribution of clusters occupied by patients at the end of the observation period (a). Forecasted distribution of
clusters occupied by patients at the end of their lives (b).
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where for 1 ≤ k ≤ K, Ik is the inertia of cluster k. In the case where w = (1, . . . , 1), F is the same objective
function aimed to be minimized by Ward’s method and the k-means algorithm.
Note that DIVCLUS-T, as described here, can also be used for prediction purposes. For example, if we
set v = (1, 1, . . . , 1, 0) and w = (0, 0, . . . , 0, 1), then the algorithm generates a decision tree predicting the
feature represented by the last column of X based on all other features.
3 Selection of the number of clusters
As in the last section, we denote by F the sum of the inertias of the leaf nodes of a clustering tree. The
mean cluster inertia of a clustering tree of K leaves is defined as f = FK . In order to find out whether our
set of data points admits a natural partitioning into a certain number of clusters, in Fig. 5 we plot the mean
cluster inertia f against the number K of clusters. In case such a natural partitioning exists, one expects
that the mean cluster inertia decreases strongly as the number of clusters increases from one to the natural
number of clusters in the data, and less strongly as the number of clusters increases further.
This plot shows that the mean cluster inertia decreases strongly for small values of the number of clusters
and less strongly for larger numbers of clusters. We make the heuristic choice K = 132, since this value enables
us to directly compare the performance of the algorithm with two simple approaches used as benchmarks, as
discussed below.
In order to quantify the effect of correlations in the data, as in the previous section we compute for each
disease block j the marginal probability pj =
1
M
∑M
i=1Xi,j . Then we create a ranking r : {1, . . . , N} →
{1, . . . , N} such that wipi(1−pi) > wjpj(1−pj) if r(i) < r(j). For a given number of clusters K we compute
f˜ =
N∑
d=K
wr(d)pr(d)(1− pr(d)). (6)
The value f˜ is the expectation value of the mean cluster inertia obtained by randomly shuffling the ones of
the matrix X independently in each column. The difference f˜ − f indicates how strongly different diseases in
the data are correlated. The pink line in Fig. 5 shows the value of f˜ as a function of K. We see that there is
a clear effect of correlations between different diagnoses in the data, which is made use of by our clustering
algorithm.
4 Robustness of our results
As explained in section C of the methods section in the main article, the weight qs,g,i,j is the rate at which
patients of sex g and age group a step from cluster i to cluster j. This rate is computed by dividing the number
sg,a,i,j of steps of patients with sex g from cluster i to cluster j in layer a by the number of observations∑K
j=1 sg,a,i,j (the size) of cluster i in layer a for sex g. If we consider our dataset as a realization of a certain
stochastic process, then qg,a,i,j is an empirical estimation of the transition probability qˆg,a,i,j inherent to this
process. We call an edge weight robust if the width of the 95% confidence interval for the estimation of qˆg,a,i,j
is smaller than λ qg,a,i,j , where λ = 0.2. To check if a given edge weight qg,i,j is robust, we proceed as follows.
Let g, a, i and j be fixed and simplify the notation to p = qg,a,i,j , pˆ = qˆg,a,i,j and s =
∑K
j=1 sg,a,i,j . The
empirical probability is a random variable
p =
1
s
s∑
i=1
Xi, (7)
where X1, . . . , Xs are iid random variables with Xi ∼ Bernoulli(pˆ). It follows from the central limit theorem
that for s→∞, √
s
pˆ(1− pˆ)
(
p− pˆ) d−→ N (0, 1), (8)
where
d−→ denotes convergence in distribution. This means that for δ > 0,
lim
s→∞P
(
pˆ ∈
[
p− δ
√
pˆ(1− pˆ)
s
, p+ δ
√
pˆ(1− pˆ)
s
])
= 2(C(δ)− 1), (9)
where C is the cumulative distribution function of the standard normal distribution. The condition that
δ
√
pˆ(1− pˆ)
s
≤ λp
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Figure 5: Mean cluster inertia as a function of the number of clusters for original and uncorrelated data.
is for sufficiently large s equivalent to p ≥ δ2/(sλ2).
For δ ' 1.96, 2(C(δ)− 1) = 0.95. Our condition for an edge to be robust is therefore that
qg,a,i,j ≥ 1.96
2
0.22
∑K
j=1 sg,a,i,j
. (10)
5 Simulated patient trajectories
We compare for each observed reduced health trajectory how much the number of patients following that
reduced trajectory as predicted from the random walk simulation differs from the actual observed number of
patients with that reduced trajectory, relative to that number. The relative discrepancy between the count
of reduced trajectories in the observed and synthetic cohort differs by less than 15% for more than 90% of
the reduced trajectories followed by more than 1,000 patients; see Fig. 3.
6 Gatekeeper clusters to the sink state
As explained in the main text, by gatekeeper clusters to a cluster j we mean clusters which tend to be
visited by patients early in their trajectory and where patients entering that cluster have a high probability
of visiting cluster j during their lifetime.
In Fig. 6 we show a two-dimensional scatter plot of the reachability of each cluster from the healthy state
(cluster 0) against the reachability of the sink state, cluster 68, from that cluster. Here, the reachability of a
cluster j from the healthy state is defined as the rate at which patients step from cluster 0 to cluster j ; the
reachability of the sink state from cluster j is the probability that, according to our random walk model, a
patient entering cluster j will reach the sink state before he or she reaches the age of 100 years.
As before we denote by sg,a,k,j the number of patients of sex g and age group a who step from cluster k
to cluster j; the value sk,j =
∑1
g=0
∑9
a=0 sg,a,k,j is the number of all patients stepping from k to j, and
qk,j =
sk,j∑K
j=1 sk,j
(11)
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Figure 6: Scatter plot of the reachability of a cluster from the healthy state versus the reachability of the sink state from that
cluster. Those clusters for which there is no other cluster with higher values of both quantities are highlighted red.
with k = 0 gives the reachability of cluster j from cluster 0.
We compute the reachability of the sink state k = 68 from a cluster j for a patient of sex s and age group
g as
rg,a,j =
(
Q10g,a ·Q10g,a+1 · · ·Q10g,9
)
j,k
, (12)
where for g ∈ {0, 1} and a ∈ {0, 1, . . . , 9}, the elements of the (K ×K)-matrix Qs,g are given by
(Qg,a)k,j = qg,a,k,j , (13)
and where as in the main text, qg,a,k,j is defined as the transition rate of patients of sex g and age group a
from cluster k to cluster j. To obtain an aggregated measure over sex and age groups, we take the weighted
mean
rj =
∑1
g=0
∑9
a=0 rg,a,jng,a,j∑1
g=0
∑9
a=0 ng,a,j
, (14)
where ng,a,j =
(∑K
k=1 sg,a,k,j
)
− sg,a,j,j is the number of patients of sex g and age group a who enter into
cluster j.
7 Performance of the method and comparison with benchmarks
To quantify how well the cluster transitions shown in Fig. 3 of the main text characterize the progression
of actual multimorbid health states, we evaluate the performance of our method for simulating patient
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trajectories in terms of several metrics and compare these metrics to two benchmark models that replace
DIVCLUS-T by a clustering scheme which assigns patients to clusters based on a single disease.
We denote for 1 ≤ d ≤ N by pd the probability that a randomly selected patient of the study cohort has
been assigned a diagnosis from the ICD-10 code block d until the end of the observation period. The total
disease burden of the study cohort at the end of the observation period is given by
Nobs = M · ‖p‖1, (15)
where M = 5, 112, 811 is the size of the cohort and p = (p1, . . . , pN ). Here, for p ≥ 1, ‖‖p denotes the Lp
norm, which, for a vector x = (x1, . . . , xL), is defined as
‖x‖p =
(
L∑
`=1
xp`
) 1
p
. (16)
Let pˆd be the marginal probability for a randomly selected patient to have been diagnosed with disease d
until the end of the observation period according to our random walk model. The vector pˆ = (pˆ1, . . . , pˆN ) is
computed as
pˆ =
K∑
k=1
cˆkp
(k), (17)
where p(k) = (p
(1)
k , . . . , p
(N)
k ), with p
(k)
d for 1 ≤ d ≤ N being the probability for a randomly selected patient
in cluster k to have disease d; cˆ(k) is the probability that a randomly selected patient of the cohort is assigned
to cluster k at the end of the observation period. The total disease burden of the study population according
to our model is
Nexp = M · ‖pˆ‖1. (18)
The quantity ‖pˆ‖1/‖p‖1 serves us as a measure for how well our model reflects the observed total disease
burden of our study cohort at the end of the observation period. We also compute the quantities ‖∆p‖1
and ‖∆p‖2, where ∆p = p − pˆ. Together with the mean cluster inertia f , these quantities measure the
performance of our algorithm in describing patient trajectories.
Benchmark method 1 consists in clustering the health states of patients according to their most recent
main diagnosis. For example, if a patient had one hospital stay with main diagnosis ‘Malignant neoplasms’
in 2008, then her or his health state at the end of that year is assigned to the cluster where all patients had
malignant neoplasms as their most recent main diagnosis. If a patient received more than one main diagnosis
in a given year, then her or his health state at the end of this year is assigned to the cluster of patients with
the less frequent main diagnosis. An additional cluster contains all patients who have not had any diagnoses
yet.
Benchmark method 2 consists in clustering patients according to the rarest disease they have been diag-
nosed with so far. For example, if a patient has been diagnosed with diagnoses from the block ‘Hypertensive
diseases’ and ‘Ischaemic heart diseases’, then he or she is a assigned to the cluster of patients who have
‘Ischaemic heart diseases’ as their rarest disease, because diagnoses of this block are rarer than ‘Hypertensive
diseases’ diagnoses. As for Benchmark method 1, an additional cluster contains all patients who have not
had any diagnoses yet.
The quantities defined above are compared in table 0. While both with DIVCLUS-T and Benchmark
method 2 we attain a mean cluster inertia of 0.48, DIVCLUS-T outperforms the latter method in terms of
the other metrics. Benchmark method 1 performs worse than DIVCLUS-T in all metrics.
‖pˆ‖1/‖p‖1 ‖∆p‖1 ‖∆p‖2 f
DIVCLUS-T 98% 0.14 0.021 0.48
Benchmark 1 88% 0.30 0.039 0.55
Benchmark 2 94% 0.17 0.029 0.48
Table 0: Comparison of the performance of our approach to modeling patient trajectories based on clustering patients using
DIVCLUS-T and two other benchmark algorithms. The meaning of the different quantities is explained in the text.
8 Inclusion and exclusion criteria for all clusters
In tables 1 to 131, the symbols 3 and 7 next to a diagnosis block indicate that this diagnosis block is an
inclusion or exclusion criterion for the given cluster, respectively. In the captions we also detail the sex
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distribution and the mean age of patients assigned to the given cluster. Note that we compute both means
on the level of observations, and not on the level of unique patients. This means that if a patient stays in a
cluster for n time steps (years), then in the computation of the means, their age and sex weighs n times as
much as the age and sex of a patient who only stays in the cluster for one year. For cluster 0 (the “healthy
cluster”), all disease blocks are exclusion criteria.
Intestinal infectious diseases (A00-A09) 7
Benign neoplasms (D10-D36) 7
Episodic and paroxysmal disorders (G40-G47) 7
Diseases of middle ear and mastoid (H65-H75) 7
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 3
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Other disorders of the musculoskeletal system and connective tissue (M95-M99) 7
Table 1: Inclusion and exclusion criteria for cluster 1. Female ratio: 46%, mean age of patients: 27.
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 3
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Table 2: Inclusion and exclusion criteria for cluster 2. Female ratio: 47%, mean age of patients: 50.
Benign neoplasms (D10-D36) 7
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 7
Other diseases of urinary system (N30-N39) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 3
Table 3: Inclusion and exclusion criteria for cluster 3. Female ratio: 100%, mean age of patients: 43.
Intestinal infectious diseases (A00-A09) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 7
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 3
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 4: Inclusion and exclusion criteria for cluster 4. Female ratio: 48%, mean age of patients: 48.
Intestinal infectious diseases (A00-A09) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 3
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 5: Inclusion and exclusion criteria for cluster 5. Female ratio: 55%, mean age of patients: 48.
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Intestinal infectious diseases (A00-A09) 3
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 6: Inclusion and exclusion criteria for cluster 6. Female ratio: 52%, mean age of patients: 21.
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Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 7
Malignant neoplasms (C00-C97) 7
In situ neoplasms (D00-D09) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Diabetes mellitus (E10-E14) 7
Obesity and other hyperalimentation (E65-E68) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Behavioural and emotional disorders with onset usually occurring in childhood and adolescence (F90-F98) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other and unspecified disorders of the circulatory system (I95-I99) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Dermatitis and eczema (L20-L30) 7
Urticaria and erythema (L50-L54) 7
Disorders of skin appendages (L60-L75) 7
Other disorders of the skin and subcutaneous tissue (L80-L99) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 7: Inclusion and exclusion criteria for cluster 7. Female ratio: 50%, mean age of patients: 35.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 3
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 8: Inclusion and exclusion criteria for cluster 8. Female ratio: 47%, mean age of patients: 45.
Intestinal infectious diseases (A00-A09) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other diseases of upper respiratory tract (J30-J39) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 3
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 9: Inclusion and exclusion criteria for cluster 9. Female ratio: 0%, mean age of patients: 30.
Malignant neoplasms (C00-C97) 7
Diabetes mellitus (E10-E14) 7
Obesity and other hyperalimentation (E65-E68) 7
Metabolic disorders (E70-E90) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Table 10: Inclusion and exclusion criteria for cluster 10. Female ratio: 53%, mean age of patients: 61.
Intestinal infectious diseases (A00-A09) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Hernia (K40-K46) 3
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 11: Inclusion and exclusion criteria for cluster 11. Female ratio: 24%, mean age of patients: 43.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 3
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other diseases of upper respiratory tract (J30-J39) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 12: Inclusion and exclusion criteria for cluster 12. Female ratio: 51%, mean age of patients: 61.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 3
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 13: Inclusion and exclusion criteria for cluster 13. Female ratio: 67%, mean age of patients: 42.
Intestinal infectious diseases (A00-A09) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 3
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Other diseases of intestines (K55-K63) 7
Diseases of liver (K70-K77) 7
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 14: Inclusion and exclusion criteria for cluster 14. Female ratio: 30%, mean age of patients: 37.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 3
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 15: Inclusion and exclusion criteria for cluster 15. Female ratio: 45%, mean age of patients: 45.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 3
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 16: Inclusion and exclusion criteria for cluster 16. Female ratio: 50%, mean age of patients: 18.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of appendix (K35-K38) 3
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 17: Inclusion and exclusion criteria for cluster 17. Female ratio: 52%, mean age of patients: 26.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Episodic and paroxysmal disorders (G40-G47) 3
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 18: Inclusion and exclusion criteria for cluster 18. Female ratio: 46%, mean age of patients: 40.
Diseases of middle ear and mastoid (H65-H75) 3
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 3
Table 19: Inclusion and exclusion criteria for cluster 19. Female ratio: 42%, mean age of patients: 10.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Episodic and paroxysmal disorders (G40-G47) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 3
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 20: Inclusion and exclusion criteria for cluster 20. Female ratio: 65%, mean age of patients: 49.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Episodic and paroxysmal disorders (G40-G47) 7
Hypertensive diseases (I10-I15) 7
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 3
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 21: Inclusion and exclusion criteria for cluster 21. Female ratio: 51%, mean age of patients: 61.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Episodic and paroxysmal disorders (G40-G47) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 3
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 22: Inclusion and exclusion criteria for cluster 22. Female ratio: 52%, mean age of patients: 25.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 3
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 23: Inclusion and exclusion criteria for cluster 23. Female ratio: 79%, mean age of patients: 37.
Diabetes mellitus (E10-E14) 3
Obesity and other hyperalimentation (E65-E68) 7
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Other forms of heart disease (I30-I52) 7
Table 24: Inclusion and exclusion criteria for cluster 24. Female ratio: 49%, mean age of patients: 71.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Episodic and paroxysmal disorders (G40-G47) 7
Disorders of lens (H25-H28) 3
Disorders of choroid and retina (H30-H36) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 25: Inclusion and exclusion criteria for cluster 25. Female ratio: 58%, mean age of patients: 71.
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Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 3
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Dorsopathies (M40-M54) 7
Table 26: Inclusion and exclusion criteria for cluster 26. Female ratio: 51%, mean age of patients: 65.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Episodic and paroxysmal disorders (G40-G47) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Infections of the skin and subcutaneous tissue (L00-L08) 3
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 27: Inclusion and exclusion criteria for cluster 27. Female ratio: 34%, mean age of patients: 31.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 3
Episodic and paroxysmal disorders (G40-G47) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 28: Inclusion and exclusion criteria for cluster 28. Female ratio: 60%, mean age of patients: 34.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 3
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 29: Inclusion and exclusion criteria for cluster 29. Female ratio: 48%, mean age of patients: 42.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 3
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 30: Inclusion and exclusion criteria for cluster 30. Female ratio: 47%, mean age of patients: 33.
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 3
Soft tissue disorders (M60-M79) 3
Osteopathies and chondropathies (M80-M94) 7
Table 31: Inclusion and exclusion criteria for cluster 31. Female ratio: 47%, mean age of patients: 52.
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Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 3
Cerebrovascular diseases (I60-I69) 7
Renal failure (N17-N19) 7
Table 32: Inclusion and exclusion criteria for cluster 32. Female ratio: 55%, mean age of patients: 74.
Benign neoplasms (D10-D36) 3
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 3
Table 33: Inclusion and exclusion criteria for cluster 33. Female ratio: 100%, mean age of patients: 48.
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 3
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 3
Other forms of heart disease (I30-I52) 7
Table 34: Inclusion and exclusion criteria for cluster 34. Female ratio: 36%, mean age of patients: 67.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 3
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 35: Inclusion and exclusion criteria for cluster 35. Female ratio: 55%, mean age of patients: 30.
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Other forms of heart disease (I30-I52) 7
Arthropathies (M00-M25) 3
Dorsopathies (M40-M54) 7
Table 36: Inclusion and exclusion criteria for cluster 36. Female ratio: 59%, mean age of patients: 68.
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Intestinal infectious diseases (A00-A09) 7
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 3
Other diseases of intestines (K55-K63) 3
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 37: Inclusion and exclusion criteria for cluster 37. Female ratio: 42%, mean age of patients: 59.
Malignant neoplasms (C00-C97) 3
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Other forms of heart disease (I30-I52) 7
Arthropathies (M00-M25) 7
Table 38: Inclusion and exclusion criteria for cluster 38. Female ratio: 48%, mean age of patients: 71.
Diabetes mellitus (E10-E14) 3
Metabolic disorders (E70-E90) 3
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Table 39: Inclusion and exclusion criteria for cluster 39. Female ratio: 50%, mean age of patients: 68.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 3
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 40: Inclusion and exclusion criteria for cluster 40. Female ratio: 58%, mean age of patients: 45.
Organic, including symptomatic, mental disorders (F00-F09) 7
Hypertensive diseases (I10-I15) 3
Other forms of heart disease (I30-I52) 3
Diseases of arteries, arterioles and capillaries (I70-I79) 7
Renal failure (N17-N19) 3
Table 41: Inclusion and exclusion criteria for cluster 41. Female ratio: 52%, mean age of patients: 80.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 3
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 42: Inclusion and exclusion criteria for cluster 42. Female ratio: 78%, mean age of patients: 48.
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 3
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 3
Table 43: Inclusion and exclusion criteria for cluster 43. Female ratio: 55%, mean age of patients: 57.
Metabolic disorders (E70-E90) 3
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 3
Cerebrovascular diseases (I60-I69) 7
Renal failure (N17-N19) 7
Table 44: Inclusion and exclusion criteria for cluster 44. Female ratio: 55%, mean age of patients: 73.
Malignant neoplasms (C00-C97) 7
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Other forms of heart disease (I30-I52) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 3
Table 45: Inclusion and exclusion criteria for cluster 45. Female ratio: 59%, mean age of patients: 64.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 3
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 46: Inclusion and exclusion criteria for cluster 46. Female ratio: 44%, mean age of patients: 44.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 3
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 47: Inclusion and exclusion criteria for cluster 47. Female ratio: 30%, mean age of patients: 44.
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Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 3
Cerebrovascular diseases (I60-I69) 3
Renal failure (N17-N19) 7
Table 48: Inclusion and exclusion criteria for cluster 48. Female ratio: 59%, mean age of patients: 80.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 3
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 49: Inclusion and exclusion criteria for cluster 49. Female ratio: 45%, mean age of patients: 14.
Intestinal infectious diseases (A00-A09) 3
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 3
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 50: Inclusion and exclusion criteria for cluster 50. Female ratio: 46%, mean age of patients: 9.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 3
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 51: Inclusion and exclusion criteria for cluster 51. Female ratio: 44%, mean age of patients: 33.
Diseases of middle ear and mastoid (H65-H75) 7
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 3
Other diseases of upper respiratory tract (J30-J39) 3
Table 52: Inclusion and exclusion criteria for cluster 52. Female ratio: 45%, mean age of patients: 21.
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 3
Dorsopathies (M40-M54) 3
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Table 53: Inclusion and exclusion criteria for cluster 53. Female ratio: 54%, mean age of patients: 59.
Intestinal infectious diseases (A00-A09) 3
Metabolic disorders (E70-E90) 3
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 54: Inclusion and exclusion criteria for cluster 54. Female ratio: 51%, mean age of patients: 22.
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Intestinal infectious diseases (A00-A09) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 3
Mood [affective] disorders (F30-F39) 3
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 55: Inclusion and exclusion criteria for cluster 55. Female ratio: 41%, mean age of patients: 43.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 3
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 56: Inclusion and exclusion criteria for cluster 56. Female ratio: 43%, mean age of patients: 40.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 3
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 57: Inclusion and exclusion criteria for cluster 57. Female ratio: 61%, mean age of patients: 42.
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 3
Other forms of heart disease (I30-I52) 3
Cerebrovascular diseases (I60-I69) 3
Renal failure (N17-N19) 7
Table 58: Inclusion and exclusion criteria for cluster 58. Female ratio: 52%, mean age of patients: 80.
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 3
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 3
Other forms of heart disease (I30-I52) 3
Cerebrovascular diseases (I60-I69) 7
Renal failure (N17-N19) 7
Table 59: Inclusion and exclusion criteria for cluster 59. Female ratio: 43%, mean age of patients: 73.
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 3
Other forms of heart disease (I30-I52) 3
Cerebrovascular diseases (I60-I69) 7
Renal failure (N17-N19) 7
Table 60: Inclusion and exclusion criteria for cluster 60. Female ratio: 50%, mean age of patients: 77.
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Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 3
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 3
Table 61: Inclusion and exclusion criteria for cluster 61. Female ratio: 50%, mean age of patients: 72.
Malignant neoplasms (C00-C97) 7
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 3
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Table 62: Inclusion and exclusion criteria for cluster 62. Female ratio: 50%, mean age of patients: 73.
Intestinal infectious diseases (A00-A09) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 3
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 63: Inclusion and exclusion criteria for cluster 63. Female ratio: 43%, mean age of patients: 43.
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Intestinal infectious diseases (A00-A09) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 3
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Other diseases of intestines (K55-K63) 3
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 64: Inclusion and exclusion criteria for cluster 64. Female ratio: 44%, mean age of patients: 55.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Inflammatory diseases of female pelvic organs (N70-N77) 3
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 65: Inclusion and exclusion criteria for cluster 65. Female ratio: 100%, mean age of patients: 35.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 3
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 66: Inclusion and exclusion criteria for cluster 66. Female ratio: 38%, mean age of patients: 34.
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 3
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Dorsopathies (M40-M54) 3
Table 67: Inclusion and exclusion criteria for cluster 67. Female ratio: 59%, mean age of patients: 66.
Hypertensive diseases (I10-I15) 3
Other forms of heart disease (I30-I52) 3
Diseases of arteries, arterioles and capillaries (I70-I79) 3
Renal failure (N17-N19) 3
Table 68: Inclusion and exclusion criteria for cluster 68. Female ratio: 49%, mean age of patients: 81.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Episodic and paroxysmal disorders (G40-G47) 7
Hypertensive diseases (I10-I15) 7
Ischaemic heart diseases (I20-I25) 3
Other forms of heart disease (I30-I52) 3
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 69: Inclusion and exclusion criteria for cluster 69. Female ratio: 46%, mean age of patients: 76.
Malignant neoplasms (C00-C97) 7
Diabetes mellitus (E10-E14) 7
Obesity and other hyperalimentation (E65-E68) 7
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 3
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Table 70: Inclusion and exclusion criteria for cluster 70. Female ratio: 41%, mean age of patients: 69.
Diabetes mellitus (E10-E14) 3
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 3
Other forms of heart disease (I30-I52) 3
Cerebrovascular diseases (I60-I69) 7
Renal failure (N17-N19) 7
Table 71: Inclusion and exclusion criteria for cluster 71. Female ratio: 45%, mean age of patients: 75.
Diabetes mellitus (E10-E14) 3
Metabolic disorders (E70-E90) 3
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 3
Other forms of heart disease (I30-I52) 7
Table 72: Inclusion and exclusion criteria for cluster 72. Female ratio: 36%, mean age of patients: 69.
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Intestinal infectious diseases (A00-A09) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 3
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 73: Inclusion and exclusion criteria for cluster 73. Female ratio: 58%, mean age of patients: 46.
Intestinal infectious diseases (A00-A09) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 3
Hernia (K40-K46) 3
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 74: Inclusion and exclusion criteria for cluster 74. Female ratio: 40%, mean age of patients: 51.
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Malignant neoplasms (C00-C97) 7
Diabetes mellitus (E10-E14) 7
Obesity and other hyperalimentation (E65-E68) 3
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Table 75: Inclusion and exclusion criteria for cluster 75. Female ratio: 52%, mean age of patients: 54.
Intestinal infectious diseases (A00-A09) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 3
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 76: Inclusion and exclusion criteria for cluster 76. Female ratio: 75%, mean age of patients: 27.
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Intestinal infectious diseases (A00-A09) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 3
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 77: Inclusion and exclusion criteria for cluster 77. Female ratio: 54%, mean age of patients: 22.
Benign neoplasms (D10-D36) 7
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 7
Inflammatory diseases of female pelvic organs (N70-N77) 3
Noninflammatory disorders of female genital tract (N80-N98) 3
Table 78: Inclusion and exclusion criteria for cluster 78. Female ratio: 100%, mean age of patients: 39.
Intestinal infectious diseases (A00-A09) 7
Metabolic disorders (E70-E90) 3
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 3
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 79: Inclusion and exclusion criteria for cluster 79. Female ratio: 45%, mean age of patients: 57.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 3
Neoplasms of uncertain or unknown behaviour (D37-D48) 3
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other diseases of upper respiratory tract (J30-J39) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 80: Inclusion and exclusion criteria for cluster 80. Female ratio: 47%, mean age of patients: 58.
Intestinal infectious diseases (A00-A09) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 3
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 81: Inclusion and exclusion criteria for cluster 81. Female ratio: 60%, mean age of patients: 41.
34
Malignant neoplasms (C00-C97) 7
Diabetes mellitus (E10-E14) 7
Obesity and other hyperalimentation (E65-E68) 7
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 3
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Table 82: Inclusion and exclusion criteria for cluster 82. Female ratio: 52%, mean age of patients: 64.
Intestinal infectious diseases (A00-A09) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 3
Mood [affective] disorders (F30-F39) 7
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Other diseases of intestines (K55-K63) 7
Diseases of liver (K70-K77) 3
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 83: Inclusion and exclusion criteria for cluster 83. Female ratio: 18%, mean age of patients: 52.
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 3
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 3
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Table 84: Inclusion and exclusion criteria for cluster 84. Female ratio: 57%, mean age of patients: 59.
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 3
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Other diseases of intestines (K55-K63) 3
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 85: Inclusion and exclusion criteria for cluster 85. Female ratio: 42%, mean age of patients: 68.
Episodic and paroxysmal disorders (G40-G47) 3
Diseases of middle ear and mastoid (H65-H75) 7
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 3
Table 86: Inclusion and exclusion criteria for cluster 86. Female ratio: 34%, mean age of patients: 38.
35
Intestinal infectious diseases (A00-A09) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 3
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 87: Inclusion and exclusion criteria for cluster 87. Female ratio: 45%, mean age of patients: 24.
36
Intestinal infectious diseases (A00-A09) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 3
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 88: Inclusion and exclusion criteria for cluster 88. Female ratio: 79%, mean age of patients: 37.
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Other forms of heart disease (I30-I52) 7
Arthropathies (M00-M25) 3
Dorsopathies (M40-M54) 3
Table 89: Inclusion and exclusion criteria for cluster 89. Female ratio: 67%, mean age of patients: 70.
37
Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 3
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 90: Inclusion and exclusion criteria for cluster 90. Female ratio: 47%, mean age of patients: 61.
38
Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Ischaemic heart diseases (I20-I25) 3
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Other disorders of the skin and subcutaneous tissue (L80-L99) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 91: Inclusion and exclusion criteria for cluster 91. Female ratio: 32%, mean age of patients: 63.
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Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Disorders of lens (H25-H28) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Renal tubulo-interstitial diseases (N10-N16) 3
Urolithiasis (N20-N23) 3
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 92: Inclusion and exclusion criteria for cluster 92. Female ratio: 34%, mean age of patients: 44.
Intestinal infectious diseases (A00-A09) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 3
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 3
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Other diseases of intestines (K55-K63) 7
Diseases of liver (K70-K77) 7
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 93: Inclusion and exclusion criteria for cluster 93. Female ratio: 40%, mean age of patients: 36.
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Intestinal infectious diseases (A00-A09) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 3
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 94: Inclusion and exclusion criteria for cluster 94. Female ratio: 52%, mean age of patients: 28.
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Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 3
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 95: Inclusion and exclusion criteria for cluster 95. Female ratio: 45%, mean age of patients: 36.
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Intestinal infectious diseases (A00-A09) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 3
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 96: Inclusion and exclusion criteria for cluster 96. Female ratio: 45%, mean age of patients: 53.
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Intestinal infectious diseases (A00-A09) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 3
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 97: Inclusion and exclusion criteria for cluster 97. Female ratio: 44%, mean age of patients: 41.
Metabolic disorders (E70-E90) 3
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 3
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Table 98: Inclusion and exclusion criteria for cluster 98. Female ratio: 43%, mean age of patients: 61.
Diabetes mellitus (E10-E14) 3
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 3
Cerebrovascular diseases (I60-I69) 7
Renal failure (N17-N19) 7
Table 99: Inclusion and exclusion criteria for cluster 99. Female ratio: 55%, mean age of patients: 77.
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Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 7
Malignant neoplasms (C00-C97) 7
In situ neoplasms (D00-D09) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Diabetes mellitus (E10-E14) 3
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Dermatitis and eczema (L20-L30) 7
Disorders of skin appendages (L60-L75) 7
Other disorders of the skin and subcutaneous tissue (L80-L99) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 100: Inclusion and exclusion criteria for cluster 100. Female ratio: 42%, mean age of patients: 47.
Benign neoplasms (D10-D36) 7
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 7
Other diseases of urinary system (N30-N39) 3
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 3
Table 101: Inclusion and exclusion criteria for cluster 101. Female ratio: 100%, mean age of patients: 51.
45
Malignant neoplasms (C00-C97) 7
Diabetes mellitus (E10-E14) 7
Obesity and other hyperalimentation (E65-E68) 7
Metabolic disorders (E70-E90) 7
Disorders of lens (H25-H28) 3
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Table 102: Inclusion and exclusion criteria for cluster 102. Female ratio: 65%, mean age of patients: 77.
Intestinal infectious diseases (A00-A09) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 3
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 103: Inclusion and exclusion criteria for cluster 103. Female ratio: 73%, mean age of patients: 30.
46
Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 3
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 104: Inclusion and exclusion criteria for cluster 104. Female ratio: 51%, mean age of patients: 45.
47
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Episodic and paroxysmal disorders (G40-G47) 7
Disorders of lens (H25-H28) 3
Disorders of choroid and retina (H30-H36) 3
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 105: Inclusion and exclusion criteria for cluster 105. Female ratio: 57%, mean age of patients: 71.
Intestinal infectious diseases (A00-A09) 7
Metabolic disorders (E70-E90) 3
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 3
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Other diseases of intestines (K55-K63) 7
Diseases of liver (K70-K77) 7
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 106: Inclusion and exclusion criteria for cluster 106. Female ratio: 22%, mean age of patients: 50.
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 3
Hypertensive diseases (I10-I15) 3
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 3
Dorsopathies (M40-M54) 7
Table 107: Inclusion and exclusion criteria for cluster 107. Female ratio: 51%, mean age of patients: 65.
Diabetes mellitus (E10-E14) 3
Obesity and other hyperalimentation (E65-E68) 3
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 3
Other forms of heart disease (I30-I52) 7
Table 108: Inclusion and exclusion criteria for cluster 108. Female ratio: 54%, mean age of patients: 63.
48
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 3
Other acute lower respiratory infections (J20-J22) 3
Other diseases of upper respiratory tract (J30-J39) 7
Hernia (K40-K46) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Diseases of male genital organs (N40-N51) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 109: Inclusion and exclusion criteria for cluster 109. Female ratio: 45%, mean age of patients: 10.
Episodic and paroxysmal disorders (G40-G47) 7
Diseases of middle ear and mastoid (H65-H75) 7
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 3
Chronic lower respiratory diseases (J40-J47) 3
Other disorders of the musculoskeletal system and connective tissue (M95-M99) 7
Table 110: Inclusion and exclusion criteria for cluster 110. Female ratio: 41%, mean age of patients: 34.
Diseases of middle ear and mastoid (H65-H75) 3
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 3
Other diseases of upper respiratory tract (J30-J39) 3
Table 111: Inclusion and exclusion criteria for cluster 111. Female ratio: 37%, mean age of patients: 9.
Intestinal infectious diseases (A00-A09) 3
Episodic and paroxysmal disorders (G40-G47) 7
Diseases of middle ear and mastoid (H65-H75) 7
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 3
Chronic lower respiratory diseases (J40-J47) 7
Other disorders of the musculoskeletal system and connective tissue (M95-M99) 7
Table 112: Inclusion and exclusion criteria for cluster 112. Female ratio: 48%, mean age of patients: 16.
Intestinal infectious diseases (A00-A09) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 3
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 3
Other diseases of intestines (K55-K63) 7
Diseases of liver (K70-K77) 7
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 113: Inclusion and exclusion criteria for cluster 113. Female ratio: 28%, mean age of patients: 55.
49
Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Other disorders of the skin and subcutaneous tissue (L80-L99) 3
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 114: Inclusion and exclusion criteria for cluster 114. Female ratio: 55%, mean age of patients: 39.
Intestinal infectious diseases (A00-A09) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 3
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 3
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 115: Inclusion and exclusion criteria for cluster 115. Female ratio: 45%, mean age of patients: 57.
50
Intestinal infectious diseases (A00-A09) 7
Malignant neoplasms (C00-C97) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other diseases of upper respiratory tract (J30-J39) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Hernia (K40-K46) 3
Other diseases of intestines (K55-K63) 3
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 116: Inclusion and exclusion criteria for cluster 116. Female ratio: 29%, mean age of patients: 58.
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 3
Soft tissue disorders (M60-M79) 3
Osteopathies and chondropathies (M80-M94) 3
Table 117: Inclusion and exclusion criteria for cluster 117. Female ratio: 52%, mean age of patients: 56.
Organic, including symptomatic, mental disorders (F00-F09) 3
Hypertensive diseases (I10-I15) 3
Other forms of heart disease (I30-I52) 3
Diseases of arteries, arterioles and capillaries (I70-I79) 7
Renal failure (N17-N19) 3
Table 118: Inclusion and exclusion criteria for cluster 118. Female ratio: 65%, mean age of patients: 86.
Intestinal infectious diseases (A00-A09) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Hypertensive diseases (I10-I15) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other diseases of upper respiratory tract (J30-J39) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Other diseases of urinary system (N30-N39) 3
Diseases of male genital organs (N40-N51) 3
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 119: Inclusion and exclusion criteria for cluster 119. Female ratio: 0%, mean age of patients: 54.
51
Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 3
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Other forms of heart disease (I30-I52) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Disorders of skin appendages (L60-L75) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 120: Inclusion and exclusion criteria for cluster 120. Female ratio: 47%, mean age of patients: 18.
52
Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 7
Malignant neoplasms (C00-C97) 7
In situ neoplasms (D00-D09) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Diabetes mellitus (E10-E14) 7
Obesity and other hyperalimentation (E65-E68) 3
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Behavioural and emotional disorders with onset usually occurring in childhood and adolescence (F90-F98) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Dermatitis and eczema (L20-L30) 7
Urticaria and erythema (L50-L54) 7
Disorders of skin appendages (L60-L75) 7
Other disorders of the skin and subcutaneous tissue (L80-L99) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 121: Inclusion and exclusion criteria for cluster 121. Female ratio: 71%, mean age of patients: 33.
53
Intestinal infectious diseases (A00-A09) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Mood [affective] disorders (F30-F39) 3
Hypertensive diseases (I10-I15) 7
Other diseases of upper respiratory tract (J30-J39) 7
Other diseases of intestines (K55-K63) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 3
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 122: Inclusion and exclusion criteria for cluster 122. Female ratio: 70%, mean age of patients: 52.
Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 7
Malignant neoplasms (C00-C97) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Dermatitis and eczema (L20-L30) 3
Disorders of skin appendages (L60-L75) 7
Other disorders of the skin and subcutaneous tissue (L80-L99) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 123: Inclusion and exclusion criteria for cluster 123. Female ratio: 57%, mean age of patients: 27.
54
Intestinal infectious diseases (A00-A09) 7
Benign neoplasms (D10-D36) 3
Episodic and paroxysmal disorders (G40-G47) 7
Diseases of middle ear and mastoid (H65-H75) 7
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 3
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Other disorders of the musculoskeletal system and connective tissue (M95-M99) 7
Table 124: Inclusion and exclusion criteria for cluster 124. Female ratio: 57%, mean age of patients: 40.
Episodic and paroxysmal disorders (G40-G47) 7
Diseases of middle ear and mastoid (H65-H75) 7
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 3
Other disorders of the musculoskeletal system and connective tissue (M95-M99) 3
Table 125: Inclusion and exclusion criteria for cluster 125. Female ratio: 43%, mean age of patients: 34.
Intestinal infectious diseases (A00-A09) 7
Episodic and paroxysmal disorders (G40-G47) 7
Diseases of middle ear and mastoid (H65-H75) 7
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 7
Other diseases of upper respiratory tract (J30-J39) 3
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 3
Other disorders of the musculoskeletal system and connective tissue (M95-M99) 7
Table 126: Inclusion and exclusion criteria for cluster 126. Female ratio: 47%, mean age of patients: 28.
Intestinal infectious diseases (A00-A09) 3
Metabolic disorders (E70-E90) 7
Hypertensive diseases (I10-I15) 7
Acute upper respiratory infections (J00-J06) 7
Other acute lower respiratory infections (J20-J22) 3
Other diseases of upper respiratory tract (J30-J39) 7
Arthropathies (M00-M25) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 127: Inclusion and exclusion criteria for cluster 127. Female ratio: 42%, mean age of patients: 10.
55
Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 7
Malignant neoplasms (C00-C97) 7
In situ neoplasms (D00-D09) 3
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Dermatitis and eczema (L20-L30) 7
Disorders of skin appendages (L60-L75) 7
Other disorders of the skin and subcutaneous tissue (L80-L99) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 128: Inclusion and exclusion criteria for cluster 128. Female ratio: 97%, mean age of patients: 38.
56
Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 7
Malignant neoplasms (C00-C97) 7
In situ neoplasms (D00-D09) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Diabetes mellitus (E10-E14) 7
Obesity and other hyperalimentation (E65-E68) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Behavioural and emotional disorders with onset usually occurring in childhood and adolescence (F90-F98) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Other and unspecified disorders of the circulatory system (I95-I99) 3
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Dermatitis and eczema (L20-L30) 7
Urticaria and erythema (L50-L54) 7
Disorders of skin appendages (L60-L75) 7
Other disorders of the skin and subcutaneous tissue (L80-L99) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 129: Inclusion and exclusion criteria for cluster 129. Female ratio: 62%, mean age of patients: 31.
57
Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 7
Malignant neoplasms (C00-C97) 7
In situ neoplasms (D00-D09) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Dermatitis and eczema (L20-L30) 7
Urticaria and erythema (L50-L54) 3
Disorders of skin appendages (L60-L75) 7
Other disorders of the skin and subcutaneous tissue (L80-L99) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 130: Inclusion and exclusion criteria for cluster 130. Female ratio: 54%, mean age of patients: 27.
58
Intestinal infectious diseases (A00-A09) 7
Other bacterial diseases (A30-A49) 7
Infections with a predominantly sexual mode of transmission (A50-A64) 7
Viral infections characterized by skin and mucous membrane lesions (B00-B09) 7
Other viral diseases (B25-B34) 7
Malignant neoplasms (C00-C97) 7
In situ neoplasms (D00-D09) 7
Benign neoplasms (D10-D36) 7
Neoplasms of uncertain or unknown behaviour (D37-D48) 7
Disorders of thyroid gland (E00-E07) 7
Diabetes mellitus (E10-E14) 7
Metabolic disorders (E70-E90) 7
Mental and behavioural disorders due to psychoactive substance use (F10-F19) 7
Schizophrenia, schizotypal and delusional disorders (F20-F29) 7
Mood [affective] disorders (F30-F39) 7
Neurotic, stress-related and somatoform disorders (F40-F48) 7
Behavioural and emotional disorders with onset usually occurring in childhood and adolescence (F90-F98) 3
Episodic and paroxysmal disorders (G40-G47) 7
Nerve, nerve root and plexus disorders (G50-G59) 7
Disorders of eyelid, lacrimal system and orbit (H00-H06) 7
Disorders of lens (H25-H28) 7
Disorders of choroid and retina (H30-H36) 7
Disorders of ocular muscles, binocular movement, accommodation and refraction (H49-H52) 7
Diseases of middle ear and mastoid (H65-H75) 7
Diseases of inner ear (H80-H83) 7
Other disorders of ear (H90-H95) 7
Hypertensive diseases (I10-I15) 7
Ischaemic heart diseases (I20-I25) 7
Other forms of heart disease (I30-I52) 7
Cerebrovascular diseases (I60-I69) 7
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (I80-I89) 7
Acute upper respiratory infections (J00-J06) 7
Influenza and pneumonia (J09-J18) 7
Other acute lower respiratory infections (J20-J22) 7
Other diseases of upper respiratory tract (J30-J39) 7
Chronic lower respiratory diseases (J40-J47) 7
Diseases of oral cavity, salivary glands and jaws (K00-K14) 7
Diseases of oesophagus, stomach and duodenum (K20-K31) 7
Diseases of appendix (K35-K38) 7
Hernia (K40-K46) 7
Noninfective enteritis and colitis (K50-K52) 7
Other diseases of intestines (K55-K63) 7
Disorders of gallbladder, biliary tract and pancreas (K80-K87) 7
Infections of the skin and subcutaneous tissue (L00-L08) 7
Dermatitis and eczema (L20-L30) 7
Urticaria and erythema (L50-L54) 7
Disorders of skin appendages (L60-L75) 7
Other disorders of the skin and subcutaneous tissue (L80-L99) 7
Arthropathies (M00-M25) 7
Dorsopathies (M40-M54) 7
Soft tissue disorders (M60-M79) 7
Osteopathies and chondropathies (M80-M94) 7
Renal tubulo-interstitial diseases (N10-N16) 7
Urolithiasis (N20-N23) 7
Other diseases of urinary system (N30-N39) 7
Diseases of male genital organs (N40-N51) 7
Disorders of breast (N60-N64) 7
Inflammatory diseases of female pelvic organs (N70-N77) 7
Noninflammatory disorders of female genital tract (N80-N98) 7
Table 131: Inclusion and exclusion criteria for cluster 131. Female ratio: 29%, mean age of patients: 14.
59
9 List of diagnosis blocks
The following table lists all the diagnosis blocks considered in this work.
ID ICD-10 Description
0 A00-A09 Intestinal infectious diseases
1 A15-A19 Tuberculosis
2 A20-A28 Certain zoonotic bacterial diseases
3 A30-A49 Other bacterial diseases
4 A50-A64 Infections with a predominantly sexual mode of transmission
5 A65-A69 Other spirochaetal diseases
6 A70-A74 Other diseases caused by chlamydiae
7 A75-A79 Rickettsioses
8 A80-A91 Viral infections of the central nervous system
9 A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers
10 B00-B09 Viral infections characterized by skin and mucous membrane lesions
11 B15-B19 Viral hepatitis
12 B20-B24 Human immunodeficiency virus [HIV] disease
13 B25-B34 Other viral diseases
14 B35-B49 Mycoses
15 B50-B64 Protozoal diseases
16 B65-B83 Helminthiases
17 B85-B89 Pediculosis, acariasis and other infestations
18 B90-B94 Sequelae of infectious and parasitic diseases
19 B95-B97 Bacterial, viral and other infectious agents
20 B99-B99 Other infectious diseases
21 C00-C97 Malignant neoplasms
22 D00-D09 In situ neoplasms
23 D10-D36 Benign neoplasms
24 D37-D48 Neoplasms of uncertain or unknown behaviour
25 D50-D53 Nutritional anaemias
26 D55-D59 Haemolytic anaemias
27 D60-D64 Aplastic and other anaemias
28 D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
29 D70-D77 Other diseases of blood and blood-forming organs
30 D80-D89 Certain disorders involving the immune mechanism
31 E00-E07 Disorders of thyroid gland
32 E10-E14 Diabetes mellitus
33 E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
34 E20-E35 Disorders of other endocrine glands
35 E40-E46 Malnutrition
36 E50-E64 Other nutritional deficiencies
37 E65-E68 Obesity and other hyperalimentation
38 E70-E90 Metabolic disorders
39 F00-F09 Organic, including symptomatic, mental disorders
40 F10-F19 Mental and behavioral disorders due to psychoactive substance use
41 F20-F29 Schizophrenia, schizotypal and delusional disorders
42 F30-F39 Mood [affective] disorders
43 F40-F48 Neurotic, stress-related and somatoform disorders
44 F50-F59 Behavioral syndromes associated with physiological disturbances and physical factors
45 F60-F69 Disorders of adult personality and behaviour
46 F70-F79 Mental retardation
47 F80-F89 Disorders of psychological development
48 F90-F98 Behavioral and emotional disorders with onset usually occurring in childhood and adolescence
49 F99-F99 Unspecified mental disorder
50 G00-G09 Inflammatory diseases of the central nervous system
51 G10-G13 Systemic atrophies primarily affecting the central nervous system
52 G20-G26 Extrapyramidal and movement disorders
53 G30-G32 Other degenerative diseases of the nervous system
54 G35-G37 Demyelinating diseases of the central nervous system
55 G40-G47 Episodic and paroxysmal disorders
56 G50-G59 Nerve, nerve root and plexus disorders
57 G60-G64 Polyneuropathies and other disorders of the peripheral nervous system
58 G70-G73 Diseases of myoneural junction and muscle
59 G80-G83 Cerebral palsy and other paralytic syndromes
60 G90-G99 Other disorders of the nervous system
60
ID ICD-10 Description
61 H00-H06 Disorders of eyelid, lacrimal system and orbit
62 H10-H13 Disorders of conjunctiva
63 H15-H22 Disorders of sclera, cornea, iris and ciliary body
64 H25-H28 Disorders of lens
65 H30-H36 Disorders of choroid and retina
66 H40-H42 Glaucoma
67 H43-H45 Disorders of vitreous body and globe
68 H46-H48 Disorders of optic nerve and visual pathways
69 H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction
70 H53-H54 Visual disturbances and blindness
71 H55-H59 Other disorders of eye and adnexa
72 H60-H62 Diseases of external ear
73 H65-H75 Diseases of middle ear and mastoid
74 H80-H83 Diseases of inner ear
75 H90-H95 Other disorders of ear
76 I00-I02 Acute rheumatic fever
77 I05-I09 Chronic rheumatic heart diseases
78 I10-I15 Hypertensive diseases
79 I20-I25 Ischaemic heart diseases
80 I26-I28 Pulmonary heart disease and diseases of pulmonary circulation
81 I30-I52 Other forms of heart disease
82 I60-I69 Cerebrovascular diseases
83 I70-I79 Diseases of arteries, arterioles and capillaries
84 I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
85 I95-I99 Other and unspecified disorders of the circulatory system
86 J00-J06 Acute upper respiratory infections
87 J09-J18 Influenza and pneumonia
88 J20-J22 Other acute lower respiratory infections
89 J30-J39 Other diseases of upper respiratory tract
90 J40-J47 Chronic lower respiratory diseases
91 J60-J70 Lung diseases due to external agents
92 J80-J84 Other respiratory diseases principally affecting the interstitium
93 J85-J86 Suppurative and necrotic conditions of lower respiratory tract
94 J90-J94 Other diseases of pleura
95 J95-J99 Other diseases of the respiratory system
96 K00-K14 Diseases of oral cavity, salivary glands and jaws
97 K20-K31 Diseases of oesophagus, stomach and duodenum
98 K35-K38 Diseases of appendix
99 K40-K46 Hernia
100 K50-K52 Noninfective enteritis and colitis
101 K55-K63 Other diseases of intestines
102 K65-K67 Diseases of peritoneum
103 K70-K77 Diseases of liver
104 K80-K87 Disorders of gallbladder, biliary tract and pancreas
105 K90-K93 Other diseases of the digestive system
106 L00-L08 Infections of the skin and subcutaneous tissue
107 L10-L14 Bullous disorders
108 L20-L30 Dermatitis and eczema
109 L40-L45 Papulosquamous disorders
110 L50-L54 Urticaria and erythema
111 L55-L59 Radiation-related disorders of the skin and subcutaneous tissue
112 L60-L75 Disorders of skin appendages
113 L80-L99 Other disorders of the skin and subcutaneous tissue
114 M00-M25 Arthropathies
115 M30-M36 Systemic connective tissue disorders
116 M40-M54 Dorsopathies
117 M60-M79 Soft tissue disorders
118 M80-M94 Osteopathies and chondropathies
119 M95-M99 Other disorders of the musculoskeletal system and connective tissue
120 N00-N08 Glomerular diseases
121 N10-N16 Renal tubulo-interstitial diseases
122 N17-N19 Renal failure
123 N20-N23 Urolithiasis
124 N25-N29 Other disorders of kidney and ureter
125 N30-N39 Other diseases of urinary system
126 N40-N51 Diseases of male genital organs
127 N60-N64 Disorders of breast
128 N70-N77 Inflammatory diseases of female pelvic organs
129 N80-N98 Noninflammatory disorders of female genital tract
130 N99-N99 Other disorders of the genitourinary system
Table 132: List of all diagnosis blocks considered in this work.
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